569 related articles for article (PubMed ID: 33011388)
41. Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells.
Costanzo F; Martínez Diez M; Santamaría Nuñez G; Díaz-Hernandéz JI; Genes Robles CM; Díez Pérez J; Compe E; Ricci R; Li TK; Coin F; Martínez Leal JF; Garrido-Martin EM; Egly JM
EMBO Mol Med; 2022 Apr; 14(4):e14841. PubMed ID: 35263037
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer.
Park S; Hong TH; Hwang S; Heeke S; Gay CM; Kim J; Jung HA; Sun JM; Ahn JS; Ahn MJ; Cho JH; Choi YS; Kim J; Shim YM; Kim HK; Byers LA; Heymach JV; Choi YL; Lee SH; Park K
EBioMedicine; 2024 Apr; 102():105062. PubMed ID: 38492534
[TBL] [Abstract][Full Text] [Related]
43. POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer.
Wang Y; Jin Y; Shen X; Zheng Q; Xue Q; Chen L; Lin Y; Li Y
Am J Surg Pathol; 2023 Sep; 47(9):1059-1066. PubMed ID: 37357936
[TBL] [Abstract][Full Text] [Related]
44. Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.
Ito F; Sato T; Emoto K; Kaizuka N; Yagi K; Watanabe R; Hashiguchi MH; Ninomiya H; Ikematsu Y; Tanaka K; Domoto H; Shiomi T
Mol Clin Oncol; 2021 Dec; 15(6):261. PubMed ID: 34790350
[TBL] [Abstract][Full Text] [Related]
45. Small cell lung cancer - news in the tumour´s biology.
Pavlíčková K; Matěj R
Cesk Patol; 2023; 59(1):18-22. PubMed ID: 37072275
[TBL] [Abstract][Full Text] [Related]
46. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B; Megyesfalvi Z; Woldmar N; Valkó Z; Schwendenwein A; Bárány N; Paku S; László V; Kiss H; Bugyik E; Lang C; Szász AM; Pizzatti L; Bogos K; Hoda MA; Hoetzenecker K; Marko-Varga G; Horvatovich P; Döme B; Schelch K; Rezeli M
Clin Transl Med; 2022 Sep; 12(9):e1060. PubMed ID: 36149789
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
[TBL] [Abstract][Full Text] [Related]
48. Tumor-derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer.
Deng C; Wang Y; Fu F; Li D; Zheng Q; Jin Y; Li Y; Chen H; Zhang Y
MedComm (2020); 2023 Oct; 4(5):e370. PubMed ID: 37789961
[TBL] [Abstract][Full Text] [Related]
49. Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.
Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Gerdan C; Dinya E; Hoetzenecker K; Hirsch FR; Lohinai Z; Dome B
Cancer Immunol Immunother; 2023 Mar; 72(3):561-578. PubMed ID: 35978199
[TBL] [Abstract][Full Text] [Related]
50. [Heterogeneity of small cell lung cancer: biological and clinicopathological implications].
Megyesfalvi Z; Bárány N; Valkó Z; Bugyik E; Paku S; Berta J; Lantos A; Fillinger J; Moldvay J; Bogos K; Rezeli M; Gálffy G; Lang C; Lohinai Z; Hécz R; Lovas T; Rényi-Vámos F; László V; Döme B
Magy Onkol; 2020 Sep; 64(3):243-255. PubMed ID: 34608895
[TBL] [Abstract][Full Text] [Related]
51. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
52. Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.
Wang Z; Liu C; Zheng S; Yao Y; Wang S; Wang X; Yin E; Zeng Q; Zhang C; Zhang G; Tang W; Zheng B; Xue L; Wang Z; Feng X; Wang Y; Ying J; Xue Q; Sun N; He J
Cancer Cell; 2024 Jun; 42(6):1106-1125.e8. PubMed ID: 38788718
[TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer.
Zhu Y; Ren W; Li S; Wu J; Hu X; Wang H; Chi K; Zhuo M; Lin D
Virchows Arch; 2024 Feb; ():. PubMed ID: 38347268
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic Regulators Open the Door to SCLC Plasticity.
Weber MC; Izzo LT; Oliver TG
Cancer Res; 2023 Nov; 83(21):3495-3497. PubMed ID: 37756567
[TBL] [Abstract][Full Text] [Related]
55. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells.
Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T
Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367
[TBL] [Abstract][Full Text] [Related]
56. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
Fujino K; Motooka Y; Hassan WA; Ali Abdalla MO; Sato Y; Kudoh S; Hasegawa K; Niimori-Kita K; Kobayashi H; Kubota I; Wakimoto J; Suzuki M; Ito T
Am J Pathol; 2015 Dec; 185(12):3164-77. PubMed ID: 26482608
[TBL] [Abstract][Full Text] [Related]
57. Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy.
Chen HZ; Bonneville R; Paruchuri A; Reeser JW; Wing MR; Samorodnitsky E; Krook MA; Smith AM; Dao T; Miya J; Wang W; Yu L; Freud AG; Allenby P; Cole S; Otterson G; Shields P; Carbone DP; Roychowdhury S
JTO Clin Res Rep; 2021 Apr; 2(4):100164. PubMed ID: 34590014
[TBL] [Abstract][Full Text] [Related]
58. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities.
Gay CM; Stewart CA; Park EM; Diao L; Groves SM; Heeke S; Nabet BY; Fujimoto J; Solis LM; Lu W; Xi Y; Cardnell RJ; Wang Q; Fabbri G; Cargill KR; Vokes NI; Ramkumar K; Zhang B; Della Corte CM; Robson P; Swisher SG; Roth JA; Glisson BS; Shames DS; Wistuba II; Wang J; Quaranta V; Minna J; Heymach JV; Byers LA
Cancer Cell; 2021 Mar; 39(3):346-360.e7. PubMed ID: 33482121
[TBL] [Abstract][Full Text] [Related]
59. ASCL1 represses a SOX9
Olsen RR; Ireland AS; Kastner DW; Groves SM; Spainhower KB; Pozo K; Kelenis DP; Whitney CP; Guthrie MR; Wait SJ; Soltero D; Witt BL; Quaranta V; Johnson JE; Oliver TG
Genes Dev; 2021 Jun; 35(11-12):847-869. PubMed ID: 34016693
[TBL] [Abstract][Full Text] [Related]
60. Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer.
Duplaquet L; So K; Ying AW; Li X; Li Y; Qiu X; Li R; Singh S; Wu XS; Liu Q; Qi J; Somerville TDD; Heiling H; Mazzola E; Lee Y; Zoller T; Vakoc CR; Doench JG; Forrester WC; Abrams T; Long HW; Niederst MJ; Kadoch C; Oser MG
bioRxiv; 2024 Jan; ():. PubMed ID: 38328215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
